Endocrine diseases ‘emerging epidemic’ after immune checkpoint inhibitor therapies

Recently approved immune checkpoint inhibitor therapies are now increasingly used for a variety of cancers and other conditions, yet clinicians are only beginning to confront a range of endocrinopathies triggered by such treatments, including thyroid disease, pituitary disorders and insulin-dependent diabetes, according to a speaker here.

Source: Endocrine diseases ‘emerging epidemic’ after immune checkpoint inhibitor therapies